Additionally, DHM ameliorates liver fibrosis by inhibiting NF-κB signaling activation, reducing the release of inflammatory cytokines including TNF-α and interleukin-1β (IL-1β), and increasing the expression of anti-apoptotic proteins Bcl-2 and Bcl-XL. Here, NFKB1 is linked to Hepatic fibrosis.